RedHill Biopharma (RDHL) Posts Q1 Loss of 5c/Share

RedHill Biopharma (NASDAQ: RDHL) reported Q1 EPS of ($0.05), $0.42 better than the analyst estimate of ($0.47).

For earnings history and earnings-related data on RedHill Biopharma (RDHL) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• XP Inc eyes US banking license as next business step
• Flexsteel (FLXS) Tops Q4 EPS by 24c, Beats on Revenue; Offers Q1 Revenue Guidance